M&A Deal Summary

Curia Acquires Integrity Bio

On July 13, 2021, Curia acquired life science company Integrity Bio from Symyx Technologies

Acquisition Highlights
  • This is Curia’s 7th transaction in the Life Science sector.
  • This is Curia’s 5th transaction in the United States.
  • This is Curia’s 1st transaction in California.

M&A Deal Summary

Date 2021-07-13
Target Integrity Bio
Sector Life Science
Buyer(s) Curia
Sellers(s) Symyx Technologies
Deal Type Divestiture

Target

Integrity Bio

Camarillo, California, United States
Integrity Bio is a provider of contract formulation research and analytical services, providing high-quality, cost-effective formulation and stability solutions for large molecule biopharmaceuticals along with Good Manufacturing Practices (GMP) fill/finish services for Phase I and II clinical trial volumes. Integrity Bio was founded in 2003 and is based in Camarillo, California.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Curia

Albany, New York, United States

Category Company
Founded 1991
Sector Life Science
Employees2,220
Revenue 402M USD (2015)
DESCRIPTION

Curia is a contract development and manufacturing organization (CDMO) providing services from drug discovery through development and manufacturing for small molecules, generic APIs, and biologics. The company draws on many years of experience and operates globally with integrated facilities in North America, Europe, and Asia. Curia was founded in 1991 and is headquartered in Albany, New York.


DEAL STATS #
Overall 9 of 11
Sector: Life Science M&A 7 of 9
Type: Divestiture M&A Deals 2 of 3
State: California M&A 1 of 2
Country: United States M&A 5 of 7
Year: 2021 M&A 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-08-01 Archimica

Lodi, Italy

Archimica offers small- to large-scale commercial manufacturing as well as analytical support for the global biopharmaceutical market. The company is specialized in custom synthesis and the manufacture of active pharmaceutical ingredients (“APIs”). Archimica was founded in 1946 and is based in Lodi, Italy.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-07-14 LakePharma

San Carlos, California, United States

LakePharma is a biologics company specializing in antibody engineering, antibody discovery, molecular engineering, protein chemistry, bioexpression, biofunction, bioprocessing, and bioanalytics. LakePharma focuses on integrated platforms to support projects throughout the drug discovery process. LakePharma was founded in 2009 and is based in San Carlos, California.

Buy -

Seller(S) 1

SELLER

Symyx Technologies

Santa Clara, California, United States

Category Company
Founded 1994
Sector Information Technology
Employees460
DESCRIPTION

Symyx Technologies, Inc. is a develops and applies high-speed combinatorial technologies to the discovery of materials for life science, chemical, and electronics applications


DEAL STATS #
Overall 2 of 2
Sector: Life Science M&A 2 of 2
Type: Divestiture M&A Deals 1 of 1
State: California M&A 1 of 1
Country: United States M&A 2 of 2
Year: 2021 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-06-24 IntelliChem

Houston, Texas, United States

IntelliChem is a technology-based information systems company that employs the latest hardware and software computer technologies to build integrated information systems.

Sell -